abbreviatioNs ACoA = anterior communicating artery; BTO = balloon test occlusion; CCF = carotid-cavernous fistula; EC-IC = extracranial-intracranial; EVD = external ventricular drain; ICA = internal carotid artery; PCoA = posterior communicating artery; PED = Pipeline Embolization Device. obJective Internal carotid artery (ICA) injury is a rare but severe complication of endonasal surgery. The authors describe their endovascular experience managing ICA injuries after transsphenoidal surgery; they review and summarize the current literature regarding endovascular techniques; and they propose a treatment algorithm based on the available evidence. MethoDs A retrospective review of 576 transsphenoidal pituitary adenoma resections was performed. Cases of ICA injury occurring at our institution and transfers from other hospitals were evaluated. Endovascular treatments for ICA injury reported in the literature were also reviewed and summarized. resUlts Seven cases were identified from the institutional cohort (mean age 46.3 years, mean follow-up 43.4 months [1-107 months]) that received endovascular treatment for ICA injury. Five injuries occurred at our institution (5 [0.9%] of 576), and 2 injuries occurred at outside hospitals. Three patients underwent ICA sacrifice by coil placement, 2 underwent lesion embolization (coil or stent-assisted coil placement), and 2 underwent endoluminal reconstruction (both with flow diversion devices). Review of the literature identified 98 cases of ICA injury treated with endovascular methods. Of the 105 total cases, 46 patients underwent ICA sacrifice, 28 underwent lesion embolization, and 31 underwent endoluminal reconstruction. Sacrifice of the ICA proved a durable solution in all cases; however, the rate of persistent neurological complications was relatively high (10 [21.7%] of 46). Lesion embolization was primarily performed by coil embolization without stenting (16 cases) and stent-assisted coiling (9 cases). Both techniques had a relatively high rate of at least some technical complication (6 [37.5%] of 16 and 5 [55.6%] of 9, respectively) and major technical complications (i.e., injury, new neurological deficit, or ICA sacrifice) (5 [31.3%] of 16 and 2 [22.2%] of 9, respectively). Endoluminal reconstruction was performed by covered stent (24 cases) and flow diverter (5 cases) placement. Covered stents showed a reasonably high rate of technical complications (10 [41.7%] of 24); however, 8 of these problems were resolved, leaving a small percentage with major technical complications (2 [8.3%] of 24). Flow diverter placement was also well tolerated, with only 1 minor technical complication. coNclUsioNs Endovascular treatments including vessel sacrifice, coil embolization (with or without stent assistance), and endoluminal reconstruction offer a tailored approach to ICA injury management after endonasal surgery. Vessel sacrifice remains the definitive treatment for acute, uncontrolled bleeding; however, vessel preservation techniques should be considered carefully in select patients. Multiple factors including vascular anatomy, injury characteristics, and risk of dual antiplatelet therapy should guide best treatment, but more study is needed (particularly with flow diverters) to refine this decision-making process. Ideally, all endovascular treatment options should be available at institutions performing endonasal surgery.
I
atrogenIc internal carotid artery (ICA) injuries are infrequent but challenging complications during endonasal surgery, with potentially disabling or fatal consequences. Injury to the ICA may be evident immediately intraoperatively with high volume arterial bleeding or may become evident unexpectedly in a delayed fashion days to years after surgery with development of a pseudoaneurysm or delayed hemorrhage. 49 Studies have reported a 0.2%-2.0% incidence rate of ICA injury during transsphenoidal surgery for pituitary adenomas. 7, 20, 49, 59, 73, 80, 82 Diagnostic catheter angiography is typically advisable if ICA injury is suspected, and endovascular intervention may be warranted.
The largest single study was reported in 1997 by Raymond and colleagues, who retrospectively identified ICA injuries in 17 (0.9%) of 1800 transsphenoidal surgeries for pituitary adenoma including 8 occlusions, 6 stenoses, and 3 pseudoaneurysms. 73 Five patients underwent permanent balloon occlusion of the ICA. Delayed epistaxis occurred in 10 patients, 5 of whom did not have a recognized arterial injury during surgery. The authors directly related 3 deaths and 5 permanent deficits to arterial injuries or their treatment. These results highlight the significant consequences that can occur as a result of ICA injury and the potential for unexpected delayed hemorrhage.
Various endovascular options are available for the treatment of iatrogenic ICA injury. In 2013, Gardner et al. reported 7 ICA injuries in 2015 endoscopic endonasal cases performed over the course of 13 years. 29 They proposed an algorithm including the use of covered stents and ICA coil sacrifice for the treatment of pseudoaneurysms and injuries presenting with active extravasation on diagnostic angiography. The treatment of delayed ICA hemorrhage and the use of other vessel-sparing techniques such as embolization with or without stent assistance and flow diversion were not addressed. To date, a comprehensive report incorporating the latest endovascular techniques for the treatment of both acute and delayed ICA injury after endonasal surgery has not been made.
In this study, we performed a retrospective review of a single institutional experience with endovascular management of intra-or postoperative ICA injury specifically following transsphenoidal surgery for pituitary adenoma. A comprehensive review of the literature on endovascular management of ICA injury following endonasal surgery was also performed. Injury details, procedural characteristics, and outcomes after endovascular treatments were evaluated, and general endovascular treatment modality recommendations are proposed based on the current series and literature review.
Methods

Patients
Institutional review board (IRB) approval was obtained for this study. Data were abstracted from medical records and an IRB-approved prospective and retrospective brain tumor surgery and intraoperative MRI database containing demographic, pre-, peri-, and postoperative data from 576 transsphenoidal surgeries performed for pituitary adenoma at our institution from 1993 to 2013. Five patients (0.9%) were identified as having undergone endovascular treatment for ICA injury after transsphenoidal surgery for pituitary adenomas. Two endovascular treatments were performed for ICA injuries sustained at an outside hospital.
Periprocedural Details
For the 5 ICA injuries that occurred at our institution, intraoperative hemostasis after ICA injury was achieved by direct packing of the sella, sphenoid sinus, and nasal cavity using Gelfoam (Pfizer) and cottonoids prior to pursuing digital subtraction angiography. Patients were transported from the operating room while anesthetized, with the surgical and anesthesia teams present during the endovascular procedure. No external ventricular drain (EVD) was placed or CT scans performed prior to angiography. Angiography was performed in the angiography suite rather than in the operating room to optimize biplanar imaging for diagnostic angiography and subsequent endovascular procedures. Four of the 5 patients were returned to the operating room after angiography for the removal of cottonoids and definitive closure. One patient (Case 4) received definitive closure prior to transfer to the angiography suite.
endovascular Procedures
For all 7 ICA injuries, patients were positioned supine and were maintained under general anesthesia while arterial access was achieved in the common femoral artery, with placement of a 6-Fr sheath. Diagnostic angiography was performed using a high-resolution biplane angiographic unit (Neurostar or Axiom Artis, Siemens Healthcare). Balloon test occlusion (BTO) was performed to examine the collateral circulation in cases intended for ICA occlusion by placement of a temporary balloon in the ICA proximal to the level of the injury, and assessing collateral circulation by subsequent selective injections of the contralateral ICA and the vertebral arteries. Assessments were made of the collateral perfusion to the territory of the balloon-occluded ICA, including supply from the anterior communicating artery (ACoA), the posterior communicating artery (PCoA), and retrograde filling via the ophthalmic artery and pial collaterals. The symmetry of the venous phase was assessed. 1 Treatment of ICA injuries was performed using 1 of 3 treatment paradigms including 1) ICA sacrifice, 2) ICA lesion embolization, and 3) ICA endoluminal reconstruction. Sacrifice of the ICA was performed using various coil systems to develop a construct covering the injured portion of the artery, spanning from proximal to the ophthalmic artery origin to the petrous ICA. Embolization of ICA lesions was achieved using coils with or without a stent-assisted system. Stent-assisted coiling was performed using the Enterprise closed-cell design stent (Cordis Neurovascular, Inc.) or the Neuroform open-cell design stent (Stryker), which were delivered as previously reported. 37, 39 Endoluminal reconstruction was performed via flow diversion with the Pipeline Embolization Device (PED, ev3) as previously reported. 38 Patients were recommended to continue aspirin for at least 1 year and clopidogrel for at least 2 months after either stent or flow diverter placement. When indicated, patients remained intubated and were taken back to the operating room for completion of the transsphenoidal surgery for resection of the pituitary adenoma.
literature search
The literature was reviewed to summarize the available endovascular treatment options for iatrogenic ICA injury during endonasal surgery. A search of MEDLINE/ PubMed, Scopus, and Embase was performed. The search strategy "internal carotid artery AND (injury OR pseudoaneurysm OR fistula) AND (endovascular OR Pipeline OR flow diverter OR stent OR coil) identified 2057 reports. Review of these articles and citations from relevant articles identified 60 pertinent articles. Data from these papers were abstracted, summarized, and evaluated.
results case characteristics
Baseline operative treatment and ICA injury characteristics including patient age, sex, prior and most recent treatment for pituitary adenoma, preoperative presentation, preangiography presentation, timing of angiography relative to most recent operative therapy, and results of angiography are listed in Table 1 . Four females and 3 males were identified, with a mean age of 46.3 years (range 27-86 years) at the time of endovascular treatment. In 4 of 5 of these cases, hemostasis was obtained with Gelfoam and cottonoids, and these patients received definitive endovascular treatment either immediately (Cases 1, 2, and 3) or 3 days after transsphenoidal surgery (Case 4). Case 5 had adequate intraoperative control of bleeding and a negative angiogram, but a small pseudoaneurysm was identified on follow-up angiography 5 days later, and endovascular treatment was performed 15 days after transsphenoidal surgery. Cases 6 and 7 were referred to our hospital with epistaxis following transsphenoidal surgery, but operative notes were not available for review. Case 6 had 2 weeks of epistaxis 2 months after transsphenoidal surgery, and Case 7 had epistaxis and coil extrusion into the nasopharynx and oropharynx 20 years after transsphenoidal surgery, ICA injury, and prior coil embolization of a pseudoaneurysm. Diagnostic angiography of the 7 endovascular cases identified 6 pseudoaneurysms (mean size 5.5 mm, median size 2.5 mm, range 2-18 mm) and 1 filling defect suggestive of active extravasation. The 3 cases that received BTO (Cases 1, 2, and 3) demonstrated good collateral filling from the contralateral circulation. Assessment of collateral circulation by standard angiography demonstrated good filling in Cases 5 and 7 and poor filling in Cases 4 and 6.
A literature review identified 60 articles and 98 cases of endovascular treatments for ICA injury following endonasal surgery (105 cases including the current series). Surgery types included 82 transsphenoidal surgeries (78.1%), 16 endonasal sinus surgeries (15.2%), 2 maxillectomies (1.9%), and 5 unspecified endonasal surgeries (4.8%). Endovascular treatments were grouped into ICA sacrifice (Table 2) , ICA endoluminal reconstruction (Table 3), and ICA lesion embolization (Table 4 Fig. 2 .
The timing of ICA injury identification was not reported for 7 of 105 cases. Figure 3 shows (16 cases) , lesion embolization (9 cases: stent-assisted coiling in 5 and only coiling in 4), and unreported stent repair type (1 case). Delayed treatments after intraoperative identification of ICA injury included embolization (13 cases: 1 balloon, 2 Onyx, 1 stent-assisted coil, 9 coils only), ICA sacrifice (10), and covered stent (5). Delayed identification of ICA injury was reported in 14 (14.3%) of 98 cases. All of these were reported to have pseudoaneurysms. Treatments included lesion embolization (5 cases: 2 stent-assisted coiling, 3 coiling), ICA sacrifice (4), covered stent (2), and flow di- version (3). The mean time from operation to endovascular treatment for these cases was 1138 days (range 2 days-20 years, median 28 days).
Endovascular ICA Sacrifice
Institutional Cases Cases 1, 2, and 3 from our institutional experience showed complete ipsilateral ICA occlusion after therapeutic sacrifice. Figure 4 shows representative angiography images (Case 2). Postoperatively, Cases 1 and 3 had no neurological deficits on most recent follow-up (107 and 58 months); however, Case 3 had mild right-sided hemiparesis and expressive aphasia postoperatively, which resolved prior to discharge. Case 2 developed a small permanent visual field defect 1 day after ICA sacrifice. Postprocedure angiography demonstrated good filling of the ipsilateral ophthalmic artery; however, a diminished retinal blush was noted.
Analysis of Institutional and Literature Cases
Literature review and the current series identified 46 cases in which the patient underwent endovascular ICA sacrifice. Devices used included balloons (26 cases 30 and methods not reported (1) 77 (Table 2) . Extracranial-intracranial (EC-IC) bypass was performed in 2 cases. 41, 73 Injury types included pseudoaneurysms (24 cases), active bleeding (10), carotid-cavernous fistula (CCF) (2), stenosis (3), dissection (1), vessel irregularity (2), and not reported (4). Clinical outcomes were not reported in 3 cases. New neurological deficits were reported in 13 (28.3%) of 46 cases. Neurological improvement was reported in 9 of 13 cases that had a neurological deficit (6 of 13 partial, 3 of 13 full), leaving 10 (21.7%) of 46 cases with at least some associated neurological deficit. Death was reported in 3 cases, with 2 from sequela of cerebral infarction (postprocedure Days 2 and 6). 43, 63 The third death was related to primary disease and not ICA sacrifice.
endovascular ica lesion embolization
Institutional Cases
Case 4 from our institutional series received stent-assisted coiling using the Enterprise stent for a wide-necked, 5-mm pseudoaneurysm. Preprocedural angiography demonstrated poor collateral circulation. Treatment was deferred for 3 days following transsphenoidal surgery to allow time for healing before starting dual antiplatelet therapy. Postprocedure angiography demonstrated neartotal obliteration of the pseudoaneurysm with stent patency. This patient had multiple preoperative comorbidities, which contributed to postprocedure morbidity (e.g., myocardial infarction, cerebral infarction), and expiration 1 month later. Case 6 received coil embolization without stent assistance for an 18-mm pseudoaneurysm 2 months after transsphenoidal surgery at an outside hospital (Fig. 5) . Prior to admission for treatment, the patient received several blood transfusions despite nasal packing for epistaxis. Preembolization angiography demonstrated poor collateral circulation. Postembolization angiography at 4 months showed coil compaction, which required placement of a Neuroform stent over the aneurysm neck and the introduction of additional coils. Brisk epistaxis occurred 8 months later, and angiography revealed pseudoaneurysm recurrence, which was near completely obliterated using Onyx (HD-500). Angiography performed 2 years later revealed complete ICA occlusion, with good collateral flow via the ophthalmic artery, ACoA, and pial collaterals, with limited PCoA collateral flow. Occlusion was likely due to Onyx coating the intraarterial stent tines and patient noncompliance with antiplatelet medication. No neurological deficits were noted in the postoperative period.
Analysis of Institutional and Literature Cases
A literature review and the current series identified 28 cases receiving endovascular ICA lesion embolization. Injury types included pseudoaneurysms (24 cases), CCF (3), and aneurysm laceration (1). Techniques included stent-as- (Table  3) . Completely successful treatment (lesion obliteration, ICA patency, no neurological deficits, no additional treatment) was achieved in 16 (57.1%) of 28 cases, which by treatment type was 4 (44.4%) of 9, 10 (62.5%) of 16, 0 (0%) of 1, and 1 (50%) of 2 cases, respectively. Minimal technical complications from stent-assisted coiling included covered stent placement for CCF recurrence (1 case) and hemiparesis with full recovery (1), while more significant complications included coil extrusion 9 months after the stent placement was removed endoscopically (1) and partially resolved hemiparesis (1). In addition, Case 4 in our series went on to have multiple strokes; however, these were in multiple vascular distributions and not due specifically to endovascular treatment. Technical complications following coil embolization without stenting occurred in 6 of 16 cases. Only 1 of these complications could be considered minor (coil migration requiring stent-assisted coiling). The remaining major technical complications (resulting in injury/ICA sacrifice/new deficit) included recurrence (3 cases; treated with ICA sacrifice [1], pseudoaneurysm trapping with EC-IC bypass [1], 33 or stent-assisted coiling and Onyx with incidental ICA sacrifice [1]), pseudoaneurysm rupture requiring ICA sacrifice (1), and coil extrusion (1). The 1 case of balloon embolization without stent was complicated by balloon deflation and fistula reopening, requiring placement of a larger balloon. One of the 2 reported Onyx embolization cases was complicated by incomplete embolization, requiring additional Onyx. New neurological deficits were noted after ICA lesion embolization in 3 (10.7%) of 28 cases. Neurological improvement was reported in 2 of 2 patients who had a neurological deficit (1 partial, 1 full).
endoluminal reconstruction
Institutional Cases
Flow diversion with the PED was used for pseudoaneurysm obliteration for Cases 5 and 7 in our series. Both cases had delayed endovascular treatment after transsphenoidal surgery (15 days and 20 years, respectively) and were considered safe candidates for dual antiplatelet therapy. Case 5 had a growing 3-mm pseudoaneurysm discovered in the early postoperative period that was treated successfully with PED placement, with clinical follow-up showing pseudoaneurysm obliteration at 6 months and no neurological deficits at 16 months after endovascular treatment (Fig. 6) . Case 7 had a recurrent 5-mm area of pseudoaneurysm near the base of a 20-year-old pseudoaneurysm previously treated with coiling at an outside hospital after transsphenoidal surgery (Fig. 7) . The patient had intermittent epistaxis and did not require nasal packing. Decreased flow in the pseudoaneurysm was noted after PED placement, and the patient suffered no new neurological deficits. Unfortunately, this patient was lost to follow-up; thus, longer clinical outcomes data are not available.
Analysis of Institutional and Literature Cases
A literature review and the current series identified 31 cases that received endovascular ICA endoluminal reconstruction. Techniques included covered stent placement (24 cases), 19 16 (Table 4) . Injury types included pseudoaneurysms (16 cases), active bleeding (12), CCF (2), and aneurysm laceration (1). Flow diversion was used exclusively for pseudoaneurysm repair. Treatment outcomes were not reported in 2 cases (1 stent method was reported and 1 flow diverter). Completely successful treatment (lesion obliteration, ICA patency, no neurological deficits, no additional treatment) was achieved in 14 (58.3%) of 24 cases, 1 of (100%) 1, and 3 (75%) of 4, respectively, for each treatment type. Only minimal technical complications were reported in 8 (80%) of 10 covered stent placements that did not have completely successful treatment including temporary stroke symptoms (1 case), abciximab for in-stent thrombosis (3) and covered stent (1), flow diverter (1), or bare stent (2) for endoleak. More significant treatment complications include rebleeding with ICA sacrifice (1 case) and interventricular hemorrhage requiring EVD placement and intensive care management (1 case); both cases resulted in mortality. New neurological deficits were noted after ICA endoluminal reconstruction in 1 (3.6%) of 28 cases that did not result in mortality, and full neurological recovery was noted. A death from sepsis unrelated to ICA injury was reported 3 months after flow diverter placement.
outcomes From institutional and literature cases
The distribution of neurological deficits by endovascular treatment type is shown in Figs. 8 and 9 . Neurological deficits associated with ICA injury treatment were reported in 19 (18.1%) of 105 cases (Fig. 8) . Full recovery was noted in 5 (26.3%) of 19 cases, partial recovery in 7 (36.8%) of 19, no recovery in 2 (10.5%) of 19, and death in 5 (26.3%) of 19 (Fig. 9) . The distribution of technical problems by endovascular treatment type for endoluminal reconstruction and lesion embolization is shown in Figs. 10 and 11 . Technical problems were reported in 24 cases (Fig. 10) , with 9 of 24 cases having major technical problems and 15 of 21 having minor technical problems reported ( Fig. 11 ; Table 5 ). Timing of postprocedural clinical follow-up was reported in 72 (68.6%) of 105 cases and ranged between 1 day and 107 months. In cases with at least 1 year of followup (33 of 72), no new neurological deficits were reported to be associated with ICA injury treatment.
Discussion
Given the severity of ICA injury, the treatment team should have a standardized protocol for definitive perioperative management during endonasal surgery. Careful technique is paramount, but even large series from experienced centers show that ICA injury occurs in 0.2%-2.0% of cases. A recent study of the Nationwide Inpatient Sample quoted a 0.1% rate of endovascular intervention following transsphenoidal surgery, with nearly identical rates between low and high volume center (0.2% vs 0.1%, respectively). 9 We recommend that neurointerventional radiology services be available whenever performing endonasal surgery. High-risk procedures should likely be performed at Comprehensive Stroke Centers, which require around the clock endovascular coverage.
3 It is not our practice to obtain preoperative angiography, even when risk factors are present, as distortion of ICA anatomy and ICA aneurysms can generally be detected on routine MRI sequences; however, preoperative angiography could be considered in higher-risk situations. The type of endovascular treatment should be selected carefully after consideration of multiple factors. Figure 12 illustrates a proposed algorithm for the management of ICA injury.
Sacrifice of the ICA with endovascular coiling remains the definitive method for managing ICA injury and should be considered strongly in cases of acute, uncontrolled bleeding. BTO or some form of angiographic assessment of collateral circulation should be performed in all patients considered for ICA sacrifice. A relatively low risk of permanent neurological deficit has been associated with BTO (0.4% in 1 study). 58, 78 Patients with intraoperative ICA injury identification and treatment were under general anesthesia for the BTO; therefore, collateral flow was assessed angiographically, 1 without the benefit of neurological assessments or post-BTO nuclear medicine SPECT imaging. 55, 75 The decision to perform ICA sacrifice in 3 cases (Cases 1, 2, and 3) was determined based on 1) good collateral filling demonstrated on BTO (all 3 cases); 2) persistent extravasation of blood observed on angiography (Case 3); and 3) contraindication for dual antiplatelet therapy (Case 3 and/or 4) and ICA injury prior to stent usage at our institution (Case 1). Cases 2 and 3 developed mild and/or transient symptoms potentially associated with coil occlusion. Including our series, 46 patients received ICA sacrifice following endonasal surgery, with an associated permanent neurological complication rate of 21.7%. No patients had recurrence of bleeding. A study from our institution reported on 37 patients who received ICA sacrifice for various indications (mainly head/ neck tumors involving the ICA and ICA aneurysms), with a 16.2% ipsilateral stroke rate within 1 month of the procedure. 87 While these results indicate that ICA sacrifice can provide durable injury control, the rate of neurological deficits following treatment can be high, and the potential future consequences as the patient ages are unclear. It is our suggestion that the default treatment strategy for ICA injury after endonasal surgery should, if possible, be an appropriate form of vessel preservation, and that endovascular ICA sacrifice should be considered only when necessary or as a salvage option.
Determining eligibility for dual antiplatelet therapy is of primary importance early in the decision-making process following identification of ICA injury. Dual antiplatelet therapy is required following stent graft or flow diverter placement to minimize risks of stent thrombosis and distal emboli, but this treatment increases the risk of perioperative hemorrhage. If the patient is deemed to have a temporary contraindication for dual antiplatelet therapy (e.g., postoperative), then delay in treatment could be considered. Factors suggesting an urgent need for treatment include active bleeding, large pseudoaneurysm, and a significant mechanism of injury. Case 5 in the current series was delayed until 15 days after surgery before PED placement over a small pseudoaneurysm. This strategy may carry an increased risk of ICA lesion rupture, which must be weighed against the risk of dual antiplatelet therapy. A literature review revealed no intracranial hematoma for the 22 patients who received initiation of dual antiplatelet therapy the same day as surgery for covered stent (16 patients), stent-assisted coiling (5), or unspecified stent (1) placement. It has been proposed that residual tumor could be a relative contraindication for dual antiplatelet therapy given the risk of bleeding from healing vasculature within the tumor. 62 Patients with active bleeding or CCF who are good candidates for dual antiplatelet therapy should initially be considered for covered stent placement. Case reports have described the use of the JoStent (Jomed International) and Symbiot self-expanding stent (Boston Scientific/Scimed) to exclude pseudoaneurysm or close lacerations. These stents have also been shown to be effective for the treatment of traumatic CCF and maintain good patency. 45 Case 3 in the current series had active bleeding identified on angiography, but the decision was made to perform ICA sacrifice instead of covered stent placement based on 1) good collateral circulation on BTO and 2) residual prolactinoma, and the potential need for future surgery increased concern for initiating dual antiplatelet therapy. A literature review indicated that covered stent placement was generally well tolerated, with 58.3% of the procedures resulting in successful treatment (lesion control, no persistent neurological deficit) with covered stent placement only and an additional 33.3% having minimal technical complications (transient stroke symptoms, abciximab for in-stent thrombosis, endovascular endoleak repair). In contrast to these results, it appears that treatment failure can be catastrophic as evident by the reported 2 deaths. One patient died after rebleeding, likely secondary to poor stent apposition and dual antiplatelet therapy, followed by an adequate BTO, ICA sacrifice, and ipsilateral ischemic stroke. 32 The other death was the result of intraventricular hemorrhage, presumably due to endoleak in a patient with already inhibited platelet function. 30 Covered stent rigidity, which can be problematic given the tortuosity of the cavernous ICA, likely contributed to both of these complications. A variety of methods have been reported to improve stent apposition and resolve endoleak including placement of coils between the stent and vessel wall and deploying bare stents or flow diverters in a telescoping manner. 32, 45, 72, 76 Another potential risk of covered stent placement is occlusion of branching arteries (e.g., ophthalmic artery), but the cited studies do not report this complication. Vasospasm has also been reported following placement of a covered stent in a tortuous ICA segment, but this resolved without consequence after intraarterial papaverine infusion. 47 In-stent thrombosis is another concerning issue, but this complication has been treated effectively, as reported by Kim et al., using abciximab in 3 of 7 cases. 44 Failure or expected failure of covered stent placement in these patients can be treated with ICA sacrifice with or without highflow EC-IC bypass, depending on the adequacy of collateral circulation. In complicated situations, other operative options include craniotomy with direct repair of the ICA within the cavernous sinus or trapping the aneurysm via cervical carotid ligation; supraclinoid ICA clip ligation can also be considered. Similar to the EC-IC bypass case in the series of Raymond et al., 73 a case report from 2001 documented an ICA injury during transsphenoidal surgery with failed BTO, ICA occlusion, and EC-IC arterial bypass from the proximal external carotid artery to the middle cerebral artery, resulting in successful ICA occlusion and bypass graft patency. 41 Rangel-Castilla et al. reviewed 235 EC-IC bypasses performed in a 7-year period. Eight of these cases occurred after ICA injury during transsphenoidal resection and/or failed endovascular management. All bypasses were patent at the end of available follow-up (3-36 months), and all cases had modified Rankin Scale scores of either 0 or 1. 72 Based on these studies, one could consider EC-IC bypass to augment the cerebral circulation after ICA injury.
Patients with a pseudoaneurysm who are good candidates for dual antiplatelet therapy should initially be evaluated for vessel preservation with either covered stent, stent-assisted coiling, or flow diverter placement. Covered stent remains a reasonable treatment option for many patients in this group for reasons described above. Stentassisted coiling facilitates aneurysm obliteration by limiting coil herniation into the parent artery and has been adopted for the treatment of certain saccular aneurysms (e.g., wide necked) 5,13 and traumatic pseudoaneurysms. 40 Currently, the 2 most commonly used devices are the Enterprise 52, 53 and Neuroform 71 stents. Case 4 in the current series achieved near-total pseudoaneurysm obliteration with good vessel patency using the Enterprise device, but the patient died of comorbidity 22 days after the procedure. In Case 6 in the current series, a Neuroform stent was used for treatment of a residual pseudoaneurysm neck, which later required additional embolization with Onyx before unintended ICA occlusion. A comparison of the Enterprise and Neuroform stents used for procedures at our institution suggested that the Enterprise stent was easier to deploy in tortuous ICA segments but was associated with increased thrombotic events compared with the Neuroform stent. 37 A literature review and the current series identified 9 cases primarily treated with stent-assisted coiling, resulting in completely successful treatment in 4 cases (44.4%) and only minor treatment complications in 3 cases (33.3%). The remaining 2 cases had partially resolved hemiparesis and coil extrusion through the nose, which was treated with transsphenoidal surgery. The PED was approved by the Food and Drug Administration in April 2011 as the first flow-diverting device for intracranial use in the US and has been shown to be particularly effective for the treatment of wide-necked, large cerebral aneurysms 15, 57 and noninferior to stent-assisted coiling for small saccular aneurysms. 14 Patients in 2 cases in the current series underwent PED placement; Case 5 achieved complete pseudoaneurysm obliteration, and Case 7 received 3 flow diverters but was lost to follow-up. Neither patient developed a postoperative neurological deficit. Amenta et al. reported complete exclusion of an ICA pseudoaneurysm at 6 months after PED placement. 4 Nerva et al. reported complete obliteration of 2 pseudoaneurysms at 2 weeks and 4 months after PED placement. 62 In the combined case series, no neurological deficits associated with PED placement were reported; however, 1 patient died of primary disease 3 months after treatment. Decision making for these patients should include factors such as urgent need for lesion control, tortuosity of ICA segment involved, presence of directly adjacent branching vessels, and pseudoaneurysm characteristics (Table 6 ). Covered stents are a reasonable option for nontortuous ICA segments when branching vessels will not interfere with deployment. Telescoping stents and coils can be used to improve apposition if needed. Flow diverters and stent-assisted coil placement may be preferred for cases in which tortuous ICA anatomy or branch vessel occlusion is a concern. Flow diverters require time (weeks to months) to thrombose the pseudoaneurysm and should not be used in cases with intermittent bleeding, enlargement, or concern for rupture. 38 A good aneurysm thrombosis rate (85%-90% at 6 months-1 year 60, 64, 69, 88 ) and the absence of risk of coil compaction or pseudoaneurysm rupture during placement make flow diversion a good treatment option for nonurgent lesions with poor coiling characteristics (e.g., wide neck or small dome due to segmental artery injury). In addition to the extended thrombose time, another disadvantage of flow diversion is that a microcatheter cannot be advanced through the mesh, which limits future options for treatment in the instance of obliteration failure. 81 Stent-assisted coiling is a good option for lesions with characteristics favorable for coiling and where there is need for urgent lesion control, with the principle risks being lesion rupture during placement and coil compaction. Again, ICA sacrifice and EC-IC bypass should be considered for patients with adequate and inadequate collaterals, respectively, if vessel preservation is deemed difficult or fails.
Patients who are poor candidates for dual antiplatelet therapy and either require urgent therapy or will never tolerate dual antiplatelet therapy have limited treatment options. ICA sacrifice should be initially considered for patients with good collateral circulation. For patients with pseudoaneurysms and poor collateral circulation, coil embolization of the lesion can be considered without stent placement. This strategy obviates the need for perioperative dual antiplatelet therapy but carries increased risk of coil compaction, rebleeding, and coil extrusion into the parent vessel or nasopharynx. This technique was used in Case 6 in the current series due to poor collateral circulation and perceived favorability of the aneurysm for coiling (i.e., narrow neck [4 mm], large aneurysm [18 mm]). Coil compaction after treatment led to enlargement of the aneurysm, which led to 2 additional endovascular treatments including stent-assisted coiling and Onyx embolization. The rate of major technical complication was high in this group (6 (37.5%) of 16 cases), and coil compaction was reported in 4 (25%) of 16 patients. Luo et al. cautioned against the use of coils alone for the treatment of acute traumatic carotid aneurysms, citing the inherent fragility, wide neck, and often indistinct anatomy of these aneurysms, 56 but these results suggest that this treatment may be a reasonable option, either as definitive or as a form of bridge therapy given the few choices available to these patients. Limited experience in 3 patients indicates that Onyx embolization may also be a good treatment option, but more experience is needed. 61, 67 conclusions Several endovascular techniques are available for the management of the early and delayed identification of ICA injury following endonasal surgery. Vessel sacrifice remains the definitive treatment option in the acute setting and for patients who cannot tolerate dual antiplatelet therapy and has been demonstrated to be reasonably well tolerated in select patients. Selection and timing of vesselsparing treatment depends on multiple factors including anatomy, collateral circulation, presence of active hemorrhage versus pseudoaneurysm, and the estimated risk of therapeutic dual antiplatelet therapy. Endovascular treatment selection should be tailored to the unique features of each case.
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